Cargando…

Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic disease: More to come with myositis in the offing

OBJECTIVE: To present the COVID-19–associated GBS, the prototypic viral-triggered autoimmune disease, in the context of other emerging COVID-19–triggered autoimmunities, and discuss potential concerns with ongoing neuroimmunotherapies. METHODS: Eleven GBS cases in four key COVID-19 hotspots are disc...

Descripción completa

Detalles Bibliográficos
Autor principal:	Dalakas, Marinos C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309518/ https://www.ncbi.nlm.nih.gov/pubmed/32518172 http://dx.doi.org/10.1212/NXI.0000000000000781

Ejemplares similares

Jeeves in the offing
por: Wodehouse, P. G. 1881-1975 (Pelham Grenville)

Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases
por: Stathopoulos, Panos, et al.
Publicado: (2022)

Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy
por: Dalakas, Marinos C.
Publicado: (2021)

Guillain Barre syndrome as a manifestation of neurological melioidosis
por: Krovvidi, Rajesh, et al.
Publicado: (2013)

IgG4-Mediated Neurologic Autoimmunities: Understanding the Pathogenicity of IgG4, Ineffectiveness of IVIg, and Long-Lasting Benefits of Anti–B Cell Therapies
por: Dalakas, Marinos C.
Publicado: (2021)

Autoimmune Neurological Disorders with IgG4 Antibodies: a Distinct Disease Spectrum with Unique IgG4 Functions Responding to Anti-B Cell Therapies
por: Dalakas, Marinos C.
Publicado: (2022)

Coexistence of myositis, transverse myelitis, and Guillain Barré syndrome following Mycoplasma pneumoniae infection in an adolescent
por: Topcu, Yasemin, et al.
Publicado: (2013)

Concurrent acute myositis and Guillain-Barre syndrome in Cytomegalovirus infection – a rare case report
por: Sakthivadivel, Varatharajan, et al.
Publicado: (2020)

COVID-19 AND NEUROLOGICAL AUTOIMMUNITY: A CASE OF SARS-COV-2-INDUCED GUILLAIN-BARRÉ SYNDROME
por: MINALYAN, ARTEM, et al.
Publicado: (2021)

Triggers of Guillain–Barré Syndrome: Campylobacter jejuni Predominates
por: Finsterer, Josef
Publicado: (2022)

The mental health care bill 2013: A disaster in the offing?
por: Antony, James T.
Publicado: (2014)

GDF 15 - A Novel Biomarker in the Offing for Heart Failure
por: George, Melvin, et al.
Publicado: (2016)

Prevalence of fatigue in Guillain-Barre syndrome in neurological rehabilitation setting
por: Ranjani, Prajna, et al.
Publicado: (2014)

Guillain-Barré Syndrome Animal Model: The First Proof of Molecular Mimicry in Human Autoimmune Disorder
por: Shahrizaila, Nortina, et al.
Publicado: (2011)

Campylobacter Infection as a Trigger for Guillain-Barré Syndrome in Egypt
por: Wierzba, Thomas F., et al.
Publicado: (2008)

COVID-19 as a Trigger of Recurrent Guillain–Barré Syndrome
por: McDonnell, Erin P., et al.
Publicado: (2020)

Hepatitis E virus as a trigger for Guillain-Barré syndrome
por: Fritz-Weltin, Miriam, et al.
Publicado: (2021)

Could Guillain–Barré syndrome be triggered by COVID‐19 vaccination?
por: Aldeeb, Maya, et al.
Publicado: (2022)

A rare neurological complication of typhoid fever: Guillain-Barre’ syndrome
por: Kapoor, Kapil, et al.
Publicado: (2014)

Autoimmune Neurogenic Dysphagia
por: Stathopoulos, Panos, et al.
Publicado: (2021)

Guillain–Barré syndrome
por: Mirian, Ario, et al.
Publicado: (2021)

The Role of Apolipoprotein E in Guillain-Barré Syndrome and Experimental Autoimmune Neuritis
por: Zhang, Hong-liang, et al.
Publicado: (2010)

Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination?
por: Khan, Zafran, et al.
Publicado: (2022)

Familial Guillain-Barré syndrome: First Indian report
por: Naik, Karkal Ravishankar, et al.
Publicado: (2012)

Bilateral Ptosis as the First Presentation of Guillain-Barre Syndrome
por: TALEBIAN, Ahmad, et al.
Publicado: (2016)

Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain–Barré Syndrome and Narcolepsy
por: Stowe, Julia, et al.
Publicado: (2019)

SARS-CoV-2 vaccination triggered Guillain-Barre syndrome
por: Scorza, Fulvio A, et al.
Publicado: (2022)

Covid-19 and Guillain-Barré syndrome: More than a coincidence!
por: El Otmani, H., et al.
Publicado: (2020)

Myositis ossificans of the hip joint causing sciatic nerve palsy following Guillain-barré syndrome: A case report
por: Sivakumaran, Dishanth, et al.
Publicado: (2021)

Trial of canakinumab, an IL-1β receptor antagonist, in patients with inclusion body myositis
por: Kosmidis, Michalis L., et al.
Publicado: (2019)

Neurological complications of immune checkpoint inhibitors: what happens when you ‘take the brakes off’ the immune system
por: Dalakas, Marinos C.
Publicado: (2018)

Beneficial or Harmful Role of Macrophages in Guillain-Barré Syndrome and Experimental Autoimmune Neuritis
por: Shen, Donghui, et al.
Publicado: (2018)

Hyperreflexic Guillain-Barré syndrome
por: Baheti, Neeraj N., et al.
Publicado: (2010)

An Update in Guillain-Barré Syndrome
por: Winer, J. B.
Publicado: (2014)

Guillain–Barré syndrome mimics
por: Tham, Sai Leong, et al.
Publicado: (2018)

Syndrome de Guillain–Barré
por: Mirian, Ario, et al.
Publicado: (2021)

Cardiogenic Shock and Guillain–Barré Syndrome as the First Manifestations of Pheochromocytoma
por: Heidarpour, Maryam, et al.
Publicado: (2021)

The first Helicobacter pylori‐induced Guillain–Barré syndrome in Sudan
por: Ahmed, Ayman, et al.
Publicado: (2023)

Reply: Comment on alemtuzumab and inclusion body myositis
por: Dalakas, Marinos C., et al.
Publicado: (2010)

Reactivation of Chronic Hepatitis C as a Potential Trigger for Guillain-Barré Syndrome
por: Molokwu, Ogochukwu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_43nvemilcbu8ia72limq71h38e